| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |